Manifestations of Cow's-Milk Protein Intolerance in Preterm Infants

Jonathan Cordova1, Sudhir Sriram, Tiffany Patton

  • 1*Section of Gastroenterology, Hepatology and Nutrition †Section of Pediatric Neonatology, University of Chicago, Chicago, IL.

Insights

Cow

Area of Science:

  • Neonatal Medicine
  • Pediatric Gastroenterology
  • Clinical Nutrition

Background:

  • Cow's-milk protein intolerance (CMPI) is often underdiagnosed in preterm infants.
  • Early recognition of CMPI is crucial for appropriate nutritional management and improved outcomes in vulnerable neonates.
  • Preterm infants present unique challenges in diagnosing feeding intolerances due to complex medical conditions.

Purpose of the Study:

  • To investigate the clinical indicators and preceding events associated with the diagnosis of cow's-milk protein intolerance (CMPI) in preterm infants.
  • To identify patterns in clinical care, such as parenteral nutrition (PN) support, that may correlate with CMPI diagnosis.
  • To enhance the understanding of CMPI presentation in a neonatal intensive care unit (NICU) setting.

Main Methods:

  • Retrospective analysis of preterm infants receiving parenteral nutrition (PN) in a level-III NICU over a 12-month period.
  • Assessment of clinical parameters including birth weight, diagnoses, PN duration/frequency, initial enteral feeds, and enteral autonomy.
  • CMPI diagnosis was confirmed by resolution of feeding intolerance upon switching from intact protein to hydrolysate or amino acid-based formulas.

Main Results:

  • Of 348 infants receiving PN, 19 (5%) were diagnosed with CMPI.
  • Requirement for multiple PN courses was significantly associated with a higher likelihood of CMPI (14/51 vs. 5/297, P < 0.001).
  • Nine infants diagnosed with CMPI initially presented with necrotizing enterocolitis (NEC), followed by persistent feeding intolerance and NEC-like recurrences.

Conclusions:

  • Recurrent feeding intolerance and "NEC-like illness" after recovery from NEC, particularly when requiring multiple PN courses, may indicate CMPI in preterm infants.
  • These clinical events suggest that CMPI should be considered in the differential diagnosis of persistent feeding issues in preterm infants, especially those with a history of NEC.
  • This study highlights the importance of considering CMPI in preterm infants with complex feeding intolerance and a history of NEC.
Abstract

Related Concept Videos

Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.7K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
37
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
762